Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIG LOTS INCBIG · Entity 75883 | Director | May 24, 2023 | May 26, 2023 |
| PETMED EXPRESS INCPETS · Entity 7326 | Director · CEO & President | April 30, 2025 | May 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIG LOTS INC
Report date May 24, 2023 · Filed May 26, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,055 |
Reported balance
After 2023-05-24 transaction · row 1
1 source rowRow 1 · 2023-05-24 · Grant · Acquired 19,003 · Balance 26,055 |
PETMED EXPRESS INC
Report date April 30, 2025 · Filed May 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 580,089 |
Reported balance
After 2025-04-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-04-30 · Sale · Disposed 58,898 · Balance 580,089 F1: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 578,524 |
Reported balance
After 2025-04-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-04-30 · Sale · Disposed 1,565 · Balance 578,524 F1: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025. F2: Includes 473,834 restricted stock units ("RSUs") that are subject to vesting in accordance with the applicable RSU award agreements. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025.
F2: Includes 473,834 restricted stock units ("RSUs") that are subject to vesting in accordance with the applicable RSU award agreements.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 30, 2025 Filed May 3, 2025 00:57 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 1,565 | $3.33 | $5,214.42 |
DisclosureSEC source: 0001040130-25-000023 · wk-form4_1746233871.xml · nonDerivative · entry 2 Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 578,524 F1 · kind: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025. F1 · shares: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025. F2 · balance_after: Includes 473,834 restricted stock units ("RSUs") that are subject to vesting in accordance with the applicable RSU award agreements. Read SEC document |
| April 30, 2025 Filed May 3, 2025 00:57 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 58,898 | $3.31 | $194,875.81 |
DisclosureSEC source: 0001040130-25-000023 · wk-form4_1746233871.xml · nonDerivative · entry 1 Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 580,089 F1 · kind: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025. F1 · shares: Shares sold solely to cover tax withholding obligations due upon vesting of restricted stock units on April 30, 2025. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 00:00 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantPerformance Share Units · Derivative | 146,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-25-000004 · wk-form4_1737158449.xml · derivative · entry 2 Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,772 Underlying: Common Stock · 146,772 shares Expires 2027-12-31 F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2027. F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2027. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 00:00 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 146,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-25-000004 · wk-form4_1737158449.xml · nonDerivative · entry 1 Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638,987 F1 · shares: Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of January 15, 2025, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting. Read SEC document |
| April 29, 2024 Filed May 1, 2024 18:22 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock -Restricted Stock Units | 483,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-24-000024 · wk-form4_1714587714.xml · nonDerivative · entry 2 Campos Sandra Yvette · CIK 0001865087 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,592 F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2022 Employee Equity Compensation Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of April 29, 2024, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting. Read SEC document |
| August 03, 2023 Filed Aug 4, 2023 18:00 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock -Restricted Stock Units | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-23-000058 · wk-form4_1691172018.xml · nonDerivative · entry 2 Campos Sandra Yvette · CIK 0001865087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2015 Outside Director Equity Compensation Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of August 3, 2023. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting. Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:22 UTC | BIG LOTS INC BIG · Entity 75883 | GrantCommon Stock | 19,003 | $0.00 | $0.00 |
DisclosureSEC source: 0000768835-23-000060 · wf-form4_168513251411819.xml · nonDerivative · entry 1 Campos Sandra Yvette · CIK 0001865087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,055 Read SEC document |
| May 25, 2022 Filed May 27, 2022 16:29 UTC | BIG LOTS INC BIG · Entity 75883 | GrantCommon Stock | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0000768835-22-000089 · wf-form4_165368333493913.xml · nonDerivative · entry 1 Campos Sandra Yvette · CIK 0001865087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,052 Read SEC document |
| May 26, 2021 Filed May 28, 2021 18:22 UTC | BIG LOTS INC BIG · Entity 75883 | GrantCommon Stock | 2,208 | $0.00 | $0.00 |
DisclosureSEC source: 0000768835-21-000083 · wf-form4_162224053426036.xml · nonDerivative · entry 1 Campos Sandra Yvette · CIK 0001865087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,208 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.